Advertisement
Screener

Panacea Life Sciences Holdings, Inc. (PLSH) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures

2.8 / 5 stars · 68/120 Roast Me

Panacea Life Sciences Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures

Panacea Life Sciences Holdings, Inc. (PLSH) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 0 shares for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-23.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2021-04-23

  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2020-12-31 was 0.00 shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2020-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2020-06-30 was 0.00 shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2020-03-31 was 0.00 shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2019 was 208.33K shares.
  • Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2018 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month
2020-12-310.00 shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23
0.00 shares
derived: sum of 2 quarters · filed 2021-04-23
0.00 shares
derived: sum of 3 quarters · filed 2021-04-23
0.00 shares
10-K/A · filed 2021-04-23
2020-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18
0.00 shares
derived: sum of 2 quarters · filed 2020-11-18
0.00 shares
10-Q · filed 2020-11-18
0.00 shares
derived: sum of 4 quarters · filed 2021-04-23
2020-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19
0.00 shares
10-Q · filed 2020-08-19
0.00 shares
derived: sum of 3 quarters · filed 2021-04-23
208.33K shares
derived: sum of 4 quarters · filed 2021-04-23
2020-03-310.00 shares
10-Q · filed 2020-06-29
0.00 shares
derived: sum of 2 quarters · filed 2021-04-23
208.33K shares
derived: sum of 3 quarters · filed 2021-04-23
208.33K shares
derived: sum of 4 quarters · filed 2021-04-23
2019-12-310.00 shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23
208.33K shares
derived: sum of 2 quarters · filed 2021-04-23
208.33K shares
derived: sum of 3 quarters · filed 2021-04-23
208.33K shares
10-K/A · filed 2021-04-23
2019-09-30208.33K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
208.33K shares
derived: sum of 2 quarters · filed 2019-11-14
208.33K shares
10-Q · filed 2019-11-14
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
0.00 shares
10-Q · filed 2019-08-14
2019-03-310.00 shares
10-Q · filed 2019-05-20
2018-12-310.00 shares
10-K · filed 2020-05-22